Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ECKERD's SALE OF AMERICAN HOME VIDEO, JBYRONS

Executive Summary

ECKERD's SALE OF AMERICAN HOME VIDEO, JBYRONS underscores the chain's renewed emphasis on its health related retail businesses. The chain announced the sale of American Home Video to Tandy Corp. on July 3, and the sale of JByrons to Amcena Corp., a private concern with retail interests, on July 5. Both deals are expected to close in early August, Eckerd said in separate releases. "This sale of JByrons, along with the previously announced American Home Video transaction and the sale of Eckerd's Apparel, is part of the corporation's strategic plan to maximize use of corporate assets and improve shareholders' return on equity in the Jack Eckerd Corp. for future years," Eckerd Chairman and President Stewart Turley stated in the July 5 release. "Following the sale of these three subsidiaries, the company will continue to develop its core operating business, Eckerd Drug Stores,. along with our specialty retail operations." While the 55 Florida-based JByrons stores contributed $7.9 mil. to the corporation's operating profits on sales of $220 mil. during the fiscal year ended July 31, 1984, operating profits declined 29% from the previous year. American Home Video, on the other hand, has consistently lost money since being acquired by Eckerd in 1981. For the fiscal years 1982-1984, the 207 VideoConcepts stores located in 29 states reported operating losses of $15.6 mil., $9.9 mil. and $5.9 mil., respectively. Sales for the video unit in 1984 were $156 mil. The price Amcena will pay for JByrons was not disclosed, however, the release noted that proceeds to Eckerd from the transaction are estimated to be "JByrons' approximate book value." The operating results of the subsidiary will be treated as a discontinued operation in Eckerd's financial statements, according to the release. The company indicated that the deal will not affect the previously announced Ross Stores' venture in central Florida. According to the July 3 release, Eckerd's after-tax proceeds resulting from the sale are estimated at approximately $100 mil. An after-tax write-off of roughly $60 mil. is expected on account of the write-off of non-deductible goodwill of $34 mil. and the adjustment of the values of other assets, the release noted. Eckerd has indicated that the write-off will be treated as a nonrecurring item in the company's books, and the operating results of American Home Video will be reported as a discontinued operation. The firm noted that the proposed transactions are subject to regulatory approval and negotiation of definitive contracts.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel